Status:
COMPLETED
A Trial of Multi-convergent Therapy for Functional Symptoms and Stress in Patients With Inflammatory Bowel Disease
Lead Sponsor:
Cardiff and Vale University Health Board
Conditions:
Inflammatory Bowel Disease
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether multi-convergent therapy is helpful to patients with inflammatory bowel disease who have functional abdominal symptoms or high perceived levels of psy...
Eligibility Criteria
Inclusion
- Diagnosis of Inflammatory Bowel Disease
- Clinical Remission of inflammatory bowel disease as defined by an adapted disease activity index and a CRP \<10
- Age 18 to 65 years
- Evidence of irritable bowel syndrome (Rome III criteria) or high perceived stress level (Levenstein perceived stress score \> 0.44)
Exclusion
- Use of steroids within 1 month of entry to study
- Initiation or change in dose of medication within 1 month of entry to the study
- Presence of ileostomy or colostomy
- Diagnosis of dementia or cognitive impairment
- Current psychosis or substance misuse
- Change in psychotropic medication in 3 months prior to entry to study
- Previous psychological interventions
- Pregnancy
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
66 Patients enrolled
Trial Details
Trial ID
NCT01426568
Start Date
January 1 2011
End Date
May 1 2013
Last Update
January 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiff and Vale University Health Board
Cardiff, South Glamorgan, United Kingdom, CF64 2XX